Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) is etiologically linked with KS, primary effusion lymphomas (PELs) and multicentric Castleman's disease. These diseases occur in AIDS and in other patients and current therapies are limited. KSHV latently infects the vast majority of tumor cells and viral DNA persists as a multiple copy, extrachromosomal, circular episome. To persist in proliferating cells, episomes must replicate and efficiently segregate to daughter nuclei. KSHV latency associated nuclear antigen (LANA) binds terminal repeat (TR) DNA to mediate KSHV episome persistence. LANA mediates TR DNA replication and binds TR DNA to tether episomes to mitotic chromosomes for efficient segregation to progeny nuclei. LANA is essential for KSHV episome maintenance and central to viral latency. The N- and C-terminal regions are essential for LANA function and bind mitotic chromosomes and TR DNA. However, the role(s) of internal domains in LANA mediated episome maintenance are unknown. We have now identified a 68 amino acid internal LANA region which exerts a critical effect on episome maintenance. We have also found that poly(ADP-ribose) polymerase-1 (PARP1) exerts a potent inhibitory effect on LANA mediated episome persistence. Small molecule inhibitors of LANA function would be powerful tools to probe LANA function and viral latency and would provide new therapeutic strategies. However, currently, no such inhibitors have been identified or developed. This work will address critical aspects of LANA biology. The newly identified internal LANA region critical for episome maintenance will be investigated, including its mechanism of action. Such knowledge will provide insight into the basic mechanisms of LANA mediated episome persistence. The biology of PARP1 inhibition of episome maintenance will be investigated. Study of this area is critical since PARP1 appears to be a key component of the host response to KSHV infection. Small molecule inhibitors of LANA function will be identified. These compounds will provide novel probes of KSHV latency and serve as potential therapeutic and preventive agents for KSHV malignancy.

Public Health Relevance

Kaposi's sarcoma-associated herpesvirus (KSHV) has a causative role in several human malignancies. KSHV infects and persists in tumor cells. This work investigates the mechanisms by which KSHV is able to persist and survive in the tumor cells. A better understanding of this viral persistence may allow development of strategies which prevent or treat KSHV tumors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA082036-14
Application #
8408796
Study Section
AIDS-associated Opportunistic Infections and Cancer Study Section (AOIC)
Program Officer
Read-Connole, Elizabeth Lee
Project Start
1999-07-01
Project End
2014-12-31
Budget Start
2013-01-01
Budget End
2013-12-31
Support Year
14
Fiscal Year
2013
Total Cost
$363,204
Indirect Cost
$159,729
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Juillard, Franceline; Tan, Min; Li, Shijun et al. (2016) Kaposi's Sarcoma Herpesvirus Genome Persistence. Front Microbiol 7:1149
Liang, Jun; Zhou, Hufeng; Gerdt, Catherine et al. (2016) Epstein-Barr virus super-enhancer eRNAs are essential for MYC oncogene expression and lymphoblast proliferation. Proc Natl Acad Sci U S A 113:14121-14126
Safavieh, Mohammadali; Khetani, Sultan; Juillard, Franceline et al. (2016) Electrical response of a B lymphoma cell line latently infected with Kaposi's sarcoma herpesvirus. Biosens Bioelectron 80:230-6
El Assal, Rami; Gurkan, Umut A; Chen, Pu et al. (2016) 3-D Microwell Array System for Culturing Virus Infected Tumor Cells. Sci Rep 6:39144
Inci, Fatih; Filippini, Chiara; Baday, Murat et al. (2015) Multitarget, quantitative nanoplasmonic electrical field-enhanced resonating device (NE2RD) for diagnostics. Proc Natl Acad Sci U S A 112:E4354-63
Hu, Zhuting; Blackman, Marcia A; Kaye, Kenneth M et al. (2015) Functional heterogeneity in the CD4+ T cell response to murine γ-herpesvirus 68. J Immunol 194:2746-56
Li, Shijun; Tan, Min; Juillard, Franceline et al. (2015) The Kaposi Sarcoma Herpesvirus Latency-associated Nuclear Antigen DNA Binding Domain Dorsal Positive Electrostatic Patch Facilitates DNA Replication and Episome Persistence. J Biol Chem 290:28084-96
Ponnusamy, Rajesh; Petoukhov, Maxim V; Correia, Bruno et al. (2015) KSHV but not MHV-68 LANA induces a strong bend upon binding to terminal repeat viral DNA. Nucleic Acids Res 43:10039-54
Shafiee, Hadi; Kanakasabapathy, Manoj Kumar; Juillard, Franceline et al. (2015) Printed Flexible Plastic Microchip for Viral Load Measurement through Quantitative Detection of Viruses in Plasma and Saliva. Sci Rep 5:9919
Beauchemin, Chantal; Moerke, Nathan J; Faloon, Patrick et al. (2014) Assay Development and High-Throughput Screening for Inhibitors of Kaposi's Sarcoma-Associated Herpesvirus N-Terminal Latency-Associated Nuclear Antigen Binding to Nucleosomes. J Biomol Screen 19:947-58

Showing the most recent 10 out of 31 publications